Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome Jun 9, 2021 10:05PM
Next-Gen Proteomics Company Nautilus Biotechnology to List on Nasdaq Through Merger with Arya Sciences Acquisition Corp III Feb 8, 2021 07:00AM
Form SC 13G ARYA Sciences Acquisitio Filed by: Bain Capital Life Sciences Fund II, L.P. Aug 13, 2020 04:17PM